Stereotaxis
STXS
97 hedge funds and large institutions have $263M invested in Stereotaxis in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 38 reducing their positions, and 19 closing their positions.
400% more call options, than puts
Call options by funds: $790K | Put options by funds: $158K
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
14% more capital invested
Capital invested by funds: $230M → $263M (+$32.6M)
0.54% less ownership
Funds ownership: 57.52% → 56.98% (-0.54%)
7% less funds holding
Funds holding: 104 → 97 (-7)
21% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 38
37% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 19
Top Buyers
| 1 |
HM
HealthCor Management
New York
|
+$3.92M |
| 2 |
Millennium Management
New York
|
+$3.29M |
| 3 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$2.09M |
| 4 |
RC
Roubaix Capital
Denver,
Colorado
|
+$2M |
| 5 |
LIM
Lagoda Investment Management
New York
|
+$1.61M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$2.73M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.77M |
| 3 |
LCM
Laurion Capital Management
New York
|
-$1.43M |
| 4 |
Two Sigma Investments
New York
|
-$1.42M |
| 5 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$1.1M |
STXS Hedge Fund Activity: Q4 2021 in Review
97 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Stereotaxis (STXS) for Q4 2021, worth a combined $263M — up 14% from $230M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of STXS and 12 opened new positions — a net loss of 7 holders — while 38 trimmed existing stakes and 30 added.
The largest buyer was HealthCor Management, opening a new position worth an estimated $3.92M. The largest seller was Morgan Stanley, cutting an estimated $2.73M.
- 97 institutional investors held Stereotaxis (STXS) as of Q4 2021, down from 104 in Q3 2021.
- Funds reported $263M of Stereotaxis stock for Q4 2021, up 14% quarter-over-quarter.
- 12 funds opened new Stereotaxis positions in Q4 2021 and 19 closed out, a net change of -7 holders.
- The largest Stereotaxis buyer in Q4 2021 was HealthCor Management, an estimated $3.92M added.
- The largest Stereotaxis seller in Q4 2021 was Morgan Stanley, an estimated $2.73M sold.
Based on aggregated 13F filings for Q4 2021.